PCVX
Vaxcyte IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.85B
P/E Ratio
—
EPS
$-6.89
Beta
1.24
52W High
$65.00
52W Low
$29.08
50-Day MA
$54.48
200-Day MA
$48.67
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Vaxcyte Inc
Vaxcyte, Inc., a pre-clinical biotech vaccine company, develops novel vaccines to prevent or treat infectious diseases globally. The company is headquartered in Foster City, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-75.00M |
| EBITDA | $-1.07B |
| Operating Margin | 0.00% |
| Return on Equity | -30.50% |
| Return on Assets | -20.20% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $20.76 |
| Price-to-Book | 2.29 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -14.43 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $144.40M |
| Float | $131.96M |
| % Insiders | 0.53% |
| % Institutions | 114.61% |
Historical Volatility
HV 10-Day
48.73%
HV 20-Day
51.37%
HV 30-Day
55.54%
HV 60-Day
46.24%
HV Rank
92.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($109.00 target)
1
Strong Buy9
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026